809 related articles for article (PubMed ID: 33975574)
1. Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis.
Kadakia A; Dembek C; Heller V; Singh R; Uyei J; Hagi K; Nosaka T; Loebel A
BMC Psychiatry; 2021 May; 21(1):249. PubMed ID: 33975574
[TBL] [Abstract][Full Text] [Related]
2. Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis.
Ostacher M; Ng-Mak D; Patel P; Ntais D; Schlueter M; Loebel A
World J Biol Psychiatry; 2018 Dec; 19(8):586-601. PubMed ID: 28264635
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of FDA-approved atypical antipsychotics for the treatment of bipolar depression: a systematic review and network meta-analysis.
Li S; Xu C; Hu S; Lai J
Eur Psychiatry; 2024 Mar; 67(1):e29. PubMed ID: 38487836
[TBL] [Abstract][Full Text] [Related]
4. Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
Citrome L; Ketter TA; Cucchiaro J; Loebel A
J Affect Disord; 2014 Feb; 155():20-7. PubMed ID: 24246116
[TBL] [Abstract][Full Text] [Related]
5. Important clinical features of atypical antipsychotics in acute bipolar depression that inform routine clinical care: a review of pivotal studies with number needed to treat.
Gao K; Yuan C; Wu R; Chen J; Wang Z; Fang Y; Calabrese JR
Neurosci Bull; 2015 Oct; 31(5):572-88. PubMed ID: 26024955
[TBL] [Abstract][Full Text] [Related]
6. Systematic Review and Network Meta-analysis: Efficacy and Safety of Second-Generation Antipsychotics in Youths With Bipolar Depression.
DelBello MP; Kadakia A; Heller V; Singh R; Hagi K; Nosaka T; Loebel A
J Am Acad Child Adolesc Psychiatry; 2022 Feb; 61(2):243-254. PubMed ID: 34420839
[TBL] [Abstract][Full Text] [Related]
7. Lurasidone, olanzapine, and quetiapine extended-release for bipolar depression: A systematic review and network meta-analysis of phase 3 trials in Japan.
Kishi T; Yoshimura R; Sakuma K; Okuya M; Iwata N
Neuropsychopharmacol Rep; 2020 Dec; 40(4):417-422. PubMed ID: 32902200
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis.
Bahji A; Ermacora D; Stephenson C; Hawken ER; Vazquez G
J Affect Disord; 2020 May; 269():154-184. PubMed ID: 32339131
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of treatments for bipolar depression.
Vázquez GH; Holtzman JN; Tondo L; Baldessarini RJ
J Affect Disord; 2015 Sep; 183():258-62. PubMed ID: 26042634
[TBL] [Abstract][Full Text] [Related]
10. Balancing benefits and harms of treatments for acute bipolar depression.
Ketter TA; Miller S; Dell'Osso B; Calabrese JR; Frye MA; Citrome L
J Affect Disord; 2014 Dec; 169 Suppl 1():S24-33. PubMed ID: 25533911
[TBL] [Abstract][Full Text] [Related]
11. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis.
Yildiz A; Siafis S; Mavridis D; Vieta E; Leucht S
Lancet Psychiatry; 2023 Sep; 10(9):693-705. PubMed ID: 37595997
[TBL] [Abstract][Full Text] [Related]
13. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
Maher AR; Theodore G
J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Nomura I; Hatano M; Iwata N
Mol Psychiatry; 2022 Feb; 27(2):1136-1144. PubMed ID: 34642461
[TBL] [Abstract][Full Text] [Related]
15. Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics.
Selle V; Schalkwijk S; Vázquez GH; Baldessarini RJ
Pharmacopsychiatry; 2014 Mar; 47(2):43-52. PubMed ID: 24549862
[TBL] [Abstract][Full Text] [Related]
16. Second-Generation Antipsychotics in Management of Acute Pediatric Bipolar Depression: A Systematic Review and Meta-analysis.
Patel RS; Veluri N; Patel J; Patel R; Machado T; Diler R
J Child Adolesc Psychopharmacol; 2021 Oct; 31(8):521-530. PubMed ID: 34665020
[No Abstract] [Full Text] [Related]
17. Treatment of bipolar depression: making sensible decisions.
Citrome L
CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
[TBL] [Abstract][Full Text] [Related]
18. Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?
Citrome L
Clin Schizophr Relat Psychoses; 2012 Jul; 6(2):76-85. PubMed ID: 22776634
[TBL] [Abstract][Full Text] [Related]
19. Acceptability of Acute and Maintenance Pharmacotherapy of Bipolar Disorder: A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Clinical Trials.
Bai Y; Yang H; Chen G; Gao K
J Clin Psychopharmacol; 2020; 40(2):167-179. PubMed ID: 32134852
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
Cruz N; Sanchez-Moreno J; Torres F; Goikolea JM; Valentí M; Vieta E
Int J Neuropsychopharmacol; 2010 Feb; 13(1):5-14. PubMed ID: 19638254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
